Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: a review of the literature

31 Oct 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Genomics and Rare Diseases

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 30382407
DOI: 10.1007/s00702-018-1934-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: a review of the literaturePMID 30382407Read ↗

Apolipoprotein E in Alzheimer's disease: an update.Semantic proximity Read ↗

The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort studySemantic proximity Read ↗

Use of genetic variation as biomarkers for Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E genotyping in Alzheimer's disease. National Institute on Aging/Alzheimer's Association Working Group.Semantic proximity Read ↗

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approachesSemantic proximity Read ↗

Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseSemantic proximity Read ↗

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.Semantic proximity Read ↗

Effects of ApoE genotype on clinical phenotypes in early-onset and late-onset Alzheimer's disease in China: Data from the PUMCH dementia cohort.Semantic proximity Read ↗

The Role of Upregulated APOE in Alzheimer's Disease EtiologySemantic proximity Read ↗

Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.Semantic proximity Read ↗

Multifaceted roles of APOE in Alzheimer diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.